Acyl sulfamides for treatment of obesity, diabetes and lipid...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/16 (2006.01) A61K 31/18 (2006.01) A61K 31/22 (2006.01) A61K 31/24 (2006.01) A61K 31/27 (2006.01) A61K 31/445 (2006.01) C07C 307/06 (2006.01) C07C 311/18 (2006.01) C07D 211/28 (2006.01) A61K 31/17 (2006.01)

Patent

CA 2434491

A class of acyl sulfamides comprises compounds that are potent ligands for PPAR gamma and generally have antagonist or partial agonist activity. The compounds may be useful in the treatment, control or prevention of obesity, non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, vascular restenosis, inflammation, and other PPAR gamma mediated diseases, disorders and conditions.

L'invention concerne une classe d'acyl-sulfamides qui renferme des composés étant de puissants ligands pour PPAR gamma et présentent généralement une activité antagoniste ou partiellement agoniste. Les composés peuvent être utiles dans le traitement, la régulation ou la prévention de l'obésité, du diabète non insulinodépendant, de l'hyperglycémie, de la dyslipidémie, de l'hyperlipidémie, de l'hypercholestérolémie, de l'hypertriglycéridémie, de l'athérosclérose, de la resténose vasculaire, de l'inflammation et d'autres maladies, troubles et conditions induites par PPAR gamma.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acyl sulfamides for treatment of obesity, diabetes and lipid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acyl sulfamides for treatment of obesity, diabetes and lipid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl sulfamides for treatment of obesity, diabetes and lipid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1575535

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.